F&V Capital Management LLC Sells 380 Shares of CVS Health Corporation $CVS

F&V Capital Management LLC cut its stake in CVS Health Corporation (NYSE:CVS) by 0.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 142,869 shares of the pharmacy operator’s stock after selling 380 shares during the period. CVS Health comprises about 2.5% of F&V Capital Management LLC’s investment portfolio, making the stock its 21st largest position. F&V Capital Management LLC’s holdings in CVS Health were worth $9,855,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Red Mountain Financial LLC bought a new position in CVS Health during the 2nd quarter worth about $293,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in CVS Health by 35.6% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 202,463 shares of the pharmacy operator’s stock worth $13,966,000 after acquiring an additional 53,120 shares in the last quarter. Patriot Financial Group Insurance Agency LLC grew its holdings in CVS Health by 3.8% during the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 17,165 shares of the pharmacy operator’s stock worth $1,184,000 after acquiring an additional 625 shares in the last quarter. Pure Financial Advisors LLC grew its holdings in CVS Health by 116.7% during the 2nd quarter. Pure Financial Advisors LLC now owns 6,529 shares of the pharmacy operator’s stock worth $450,000 after acquiring an additional 3,516 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its holdings in CVS Health by 815.2% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after acquiring an additional 2,372,121 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.22% of the stock is owned by insiders.

CVS Health Stock Performance

Shares of CVS Health stock opened at $77.48 on Friday. The firm has a market capitalization of $98.27 billion, a P/E ratio of 21.64, a PEG ratio of 0.85 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average price of $70.37 and a 200 day moving average price of $67.27. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $77.76.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s revenue was up 8.4% on a year-over-year basis. During the same period last year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $78.00 target price on shares of CVS Health in a report on Tuesday, August 26th. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and increased their price target for the company from $71.00 to $82.00 in a research report on Thursday, August 14th. Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Finally, Zacks Research lowered shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $78.25.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.